Studies Conducted at University of California San Francisco (UCSF) on Psoriasis Recently Reported (Ct-p17 Adalimumab Biosimilar In Patients With Moderate-to-severe Chronic Plaque Psoriasis: an Open-label Extension of a Phase 3 ...)

Media coverage

• Title	Studies Conducted at University of California San Francisco (UCSF) on Psoriasis Recently Reported (Ct-p17 Adalimumab Biosimilar In Patients With Moderate-to-severe Chronic Plaque Psoriasis: an Open-label Extension of a Phase 3 ...)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	18/04/25
  Persons	Mark Lebwohl